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Abstract
Background: The human bacterial pathogen Campylobacter jejuni contains two subspecies: C. jejuni
subsp. jejuni (Cjj) and C. jejuni subsp. doylei (Cjd). Although Cjd strains are isolated infrequently in
many parts of the world, they are obtained primarily from human clinical samples and result in an
unusual clinical symptomatology in that, in addition to gastroenteritis, they are associated often
with bacteremia. In this study, we describe a novel multiplex PCR method, based on the nitrate
reductase (nap) locus, that can be used to unambiguously subspeciate C. jejuni isolates.
Results: Internal and flanking napA and napB primer sets were designed, based on existing C. jejuni
and Campylobacter coli genome sequences to create two multiplex PCR primer sets, nap mpx1 and
nap mpx2. Genomic DNA from 161 C. jejuni subsp. jejuni (Cjj) and 27 C. jejuni subsp. doylei (Cjd)
strains were amplified with these multiplex primer sets. The Cjd strains could be distinguished
clearly from the Cjj strains using either nap mpx1 or mpx2. In addition, combination of either nap
multiplex method with an existing lpxA speciation multiplex method resulted in the unambiguous
and simultaneous speciation and subspeciation of the thermophilic Campylobacters. The Cjd nap
amplicons were also sequenced: all Cjd strains tested contained identical 2761 bp deletions in napA
and several Cjd strains contained deletions in napB.
Conclusion: The nap multiplex PCR primer sets are robust and give a 100% discrimination of C.
jejuni  subspecies. The ability to rapidly subspeciate C. jejuni as well as speciate thermophilic
Campylobacter species, most of which are pathogenic in humans, in a single amplification will be of
value to clinical laboratories in strain identification and the determination of the environmental
source of campylobacterioses caused by Cjd. Finally, the sequences of the Cjd napA and napB loci
suggest that Cjd  strains arose from a common ancestor, providing clues as to the potential
evolutionary origin of Cjd.
Background
Campylobacter spp. are a common cause of acute bacterial
gastroenteritis in humans [1,2]. The majority of campylo-
bacterioses are caused by C. jejuni and are linked primarily
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to untreated water or consumption of poultry and raw
milk [2]. C. jejuni has been divided into two subspecies: C.
jejuni subsp. jejuni (Cjj) and C. jejuni subsp. doylei (Cjd).
Cjd strains were isolated originally as "gastric campylo-
bacter-like organisms type 2 (GCLO2)" from human gas-
tric biopsies [4] and "nitrate-negative campylobacter-like
organisms (NNC)" from Australian pediatric patients
with gastroenteritis [5]. As the "NNC" designation sug-
gests, the characteristic feature of Cjd, used commonly to
distinguish Cjd strains from Cjj strains, is the inability to
reduce nitrate. Other phenotypic characteristics, such as
variable growth at 42°C [6], high susceptibility to cepha-
lothin [6], and the absence of γ-glutamyl transferase
(GGT) and L-arginine arylamidase activity [7] have been
associated also with Cjd; however, like Cjj, all Cjd strains
are hippuricase positive.
Cjd strains also differ from Cjj  in two other clinically-
related aspects: first, Cjd strains can be found throughout
the gastrointestinal tract, leading to both gastritis [4,8]
and enteritis [6,9-11], and are obtained often from pedi-
atric patients [6,9,11,12]. Second, in South Africa, unlike
Cjj strains, Cjd strains are isolated more often from blood
cultures than from stool cultures [3]; Cjd  was isolated
from 24% of the Campylobacter-positive blood cultures
[3], in contrast to 7.7% of the Campylobacter-positive stool
cultures, obtained at Red Cross Children's Hospital, Cape
Town, during the years 1990–2005. Additionally, Morey
reported that Cjd was isolated from 85.2% of Campylo-
bacter/Helicobacter-related bacteremia cases in Australia
during a five-year period [12].
In some parts of the world, notably South Africa, Cjd
strains represent a significant proportion of the total
campylobacters isolated from human clinical samples;
16% of the non-Cjj/coli Campylobacter strains isolated in
Cape Town, South Africa were Cjd. However, despite the
unusual clinical symptomatology and relatively high
prevalence in certain parts of the world, Cjd is generally
isolated infrequently and few strains exist (compared to
Cjj) for this subspecies. One possible reason is that many
clinical laboratories do not characterize Campylobacter iso-
lates past the genus level, much less subspeciate C. jejuni
isolates as Cjj or Cjd. It is also likely that both the suscep-
tibility of Cjd to cephalothin and variable growth at 42°C
prevents the isolation of a substantial number of Cjd
strains under normal Cjj  isolation conditions; the Cjd
strains isolated in South Africa were obtained using the
Cape Town Protocol [3] which uses passive filtration
through a 0.65 μM membrane filter, growth at 37°C and
no antibiotic selection.
Another factor in the lack of subspeciation characteriza-
tion of C. jejuni strains is the absence of a rapid test to dis-
tinguish Cjj from Cjd. Phenotypic characterization of Cjd,
based on the absence of nitrate reductase activity, remains
the primary means of identification; however, such nitrate
reductase assays require a large number of cells and can
take 24–48 h. Additionally, nitrate reductase assays
require pure cultures; mixtures of Cjj and Cjd cells would
type as nitrate+/Cjj.
Many commonly used molecular-based Campylobacter
detection methods cannot be used to subspeciate C. jejuni
due to the high similarity between the two subspecies.
Molecular-based methods that can subspeciate C. jejuni
do exist, based on hybridization [7], amplified fragment
length polymorphism fingerprinting [13,14], or charac-
terization of the 16S/23S rDNA internal spacer region
[15]; however, these methods are lengthy or require spe-
cialized and costly equipment. In this study we present a
simple, novel multiplex PCR method that can be used to
unambiguously subspeciate C. jejuni.
Results
Development of the napAB multiplex subspeciation PCR
Preliminary results from C. jejuni DNA microarray experi-
ments, using Cjd strain RM2095 as a tester strain, indi-
cated that, in addition to other loci, the napA and napB
genes in strain RM2095 were either absent or highly diver-
gent with respect to Cjj napA and napB (Parker et al., sub-
mitted for publication). Since napA and napB encode the
large and small subunits of nitrate reductase, respectively,
this was not unexpected, given the absence of nitrate
reductase activity in RM2095. Thus, the microarray results
suggested that the nap  phenotype in RM2095 was due
most likely to deletions in napA and/or napB and that
these results might be extended to Cjd in general; a loss of
function in either subunit would result in a loss of enzyme
activity. Therefore, an obvious target for a subspeciation
multiplex PCR would be the nap locus. The nap locus in
several  Campylobacter  species consists of six genes (in
order):  napA,  napG,  napH,  napB,  napL, and napD.
Upstream of napA in Cjj and C. coli is the tpx gene, encod-
ing a thiol peroxidase. The conservation of gene order and
high nt identity between C. jejuni and C. coli at this locus
suggested that primers designed to amplify both species
should also amplify Cjd strains.
Therefore, the sequences of the nap regions (tpx to napD)
of three strains (Cjj NCTC 11168, Cjj RM1221 and C. coli
RM2228), obtained from the genome sequence for each
strain [GenBank: AL111168, GenBank: CP000025, and
GenBank: AAFL00000000, respectively], were aligned and
four primer pairs were designed to regions of high conser-
vation within the alignment: primers internal to and
flanking napA, and primers internal to and flanking napB.
The primers were organized into two multiplex primer
sets: nap mpx1 and nap mpx2 (Table 1). A representativeBMC Microbiology 2007, 7:11 http://www.biomedcentral.com/1471-2180/7/11
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gel illustrating the nap mpx1 and nap mpx2 amplicons is
presented in Fig. 1A.
Since napA is quite large (~2.8 kb), Cjj strains would not
be expected to amplify with the napA flanking primers
under standard PCR conditions; however, both Cjj strains
did amplify with the napA internal primer set (1454 bp:
Fig. 1A). The Cjd strains did not amplify with the napA
internal primer set but did amplify with the napA flanking
primers. The resulting amplicon (1240 bp: Fig 1A) was
reduced in size from that predicted for Cjj by about 2.8 kb,
indicating the presence of a deletion within napA; ampli-
fication with different sets of flanking primers indicated
that this deletion extended into napG (data not shown).
Noteworthy also was the fact that the Cjd strains could be
divided into two classes, differentiated by an apparent
presence or absence of napB. The "napA-napB+" strains
(D3, D4: Fig 1A), termed Cjd1, amplified with the napB
internal primer set (326 bp: Fig. 1A) and gave a full length
amplicon (973 bp: Fig 1A) with the napB flanking primer
set. The "napA-napB-" strains (D1, D2: Fig 1A), termed
Cjd2, gave a reduced length amplicon (494 bp: Fig 1A)
with the napB flanking primer set, indicating the presence
of a napB deletion. Both classes would be unable to reduce
nitrate, based on the common napA deletion.
Validation of the nap multiplex PCR using additional 
Campylobacter genomic DNAs
To test the specificity of the nap mpx primer sets, an addi-
tional 20 human clinical Cjd strains and 158 human clin-
ical, animal and environmental Cjj strains were amplified
using the nap mpx2 primer set. The PCR results were iden-
tical to those presented in Fig. 1A [Table S1, see additional
file 1] with two exceptions. The HS:63 Penner serotype
reference strain, listed originally as Cjj, amplified as a Cjd2
isolate; however, this serotype has been seen previously in
Cjd isolates [16] and therefore this strain may have been
misidentified as a Cjj. Also, one Cjd strain amplified as a
Cjj isolate; a second nitrate reductase test on this strain
indicated that the strain was mis-typed originally.
Genomic DNA from the C. coli strain RM2228 amplified
also with the nap mpx2 primer set; the resulting banding
pattern was identical to that of Cjj (data not shown). Con-
sequently, representatives of the remaining non-jejuni/coli
Campylobacter  spp. were amplified using the nap  mpx2
primer set. Genomic DNA from five of these species [C.
upsaliensis  (RM3195),  C. lari (RM2100),  C. helveticus
(RM3228), C. sputorum (RM3237) and C. mucosalis
(RM3234)] amplified, although the banding patterns
were distinct from those in Fig. 1A [Table S1, see addi-
tional file 1]. Therefore, 107 additional strains of these
five species and 10 additional C. coli strains were ampli-
fied using both primer sets. All of the C. coli strains and
some of the C. upsaliensis strains produced both of the Cjj-
characteristic 1454 bp and 1016 bp bands following
amplification with nap mpx2 (11/11 and 23/72, respec-
tively; [Table S1, see additional file 1]). Moreover, the
banding patterns for many of these 34 C. coli and C. upsa-
liensis strains were similar to those seen in Fig. 1A for both
multiplex primer sets; therefore, C. coli and C. upsaliensis
strains could be confused potentially with Cjj isolates.
Table 1: nap and lpxA multiplex primers
nap mpx1:
napAL2 Flanking 5' CTT TAG AAG GGC TTT TAG CTC GTG C 3'
napAR4 Flanking 5' ATT TCC CTG CAA GAT AAA ATC TGT AGC 3'
napBIF Internal 5' AGA AAA GCA AGT TTA GAA AAT GAA AAT AA 3'
napBIR Internal 5' GCA TCA CTT TGT GGA ACA TGA CA 3'
nap mpx2:
napAIF3 Internal 5' TAG AAC AAA TAA TAT CGA TCC AAA TGC 3'
napAIR3 Internal 5' AAA AGT GTA TCA TCT TCG CTA TAA CCC 3'
napBL Flanking 5' GGA ATG ATA CAT AGA GGG ATT ATT TTT G 3'
napBR Flanking 5' AAT TTC ACC TTT ATC AGT GCC TAT ATA 3'
lpxA:
KK2 5' CAA TCA TGW GCN ATA TGR CAA TAN GCC 3'
lpxAC. coli 5' AGA CAA ATA AGA GAG AAT CAG 3'
lpxAC. jejuni 5' ACA ACT TGG TGA CGA TGT TGT A 3'
Cl0122 5' CTT ACC AAA TGT TAA AAT AGG C 3'
lpxAC. upsaliensis 5' AAG TCG TAT ATT TTC YTA CGC TTG TGT G 3'
lpxAC. coli, lpxAC. jejuni and lpxAC. upsaliensis are from Klena et al. [17]. KK2 and Cl0122 are derived from lpxARKK2m and lpxAC. lari, respectively 
[17]; the Cl0122/KK2 amplicon is 2 bp longer than the respective lpxARKK2m/lpxAC. lari amplicon.BMC Microbiology 2007, 7:11 http://www.biomedcentral.com/1471-2180/7/11
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Combination of the nap and lpxA multiplex PCRs gives 
unambiguous speciation and subspeciation of 
thermophilic campylobacters
If the nap  multiplex PCRs were performed on strains
already speciated as C. jejuni, then the non-specificity of
the nap PCR towards C. coli and C. upsaliensis would not
be of concern. However, in many instances, food, animal
and environmental samples contain multiple Campylo-
bacter species, especially C. jejuni and C. coli. In this case,
the non-specificity of the nap PCR would not permit accu-
rate identification. A PCR speciation method for ther-
mophilic Campylobacter spp, based on the lipid A gene
lpxA, was published recently [17]. Therefore, to extend the
discriminatory power of the nap  subspeciation PCR
method, we tested whether unambiguous speciation and
subspeciation of thermophilic Campylobacter spp. would
be feasible by combining the lpxA and nap mpx PCR meth-
ods. Genomic DNAs from five thermophilic Campylo-
bacter species were amplified with the nine-primer nap/
lpxA primer set. Unique banding patterns were obtained
for all species/subspecies (Fig. 1B), indicating that unam-
biguous speciation and subspeciation of thermophilic
campylobacters can be accomplished with only one
amplification.
Characterization of the Cjd napB and napA loci
As described above, the Cjd strains were subdivided into
two groups based on the apparent presence (Cjd1) or
absence (Cjd2) of napB. To characterize the Cjd napB
genes, the amplicons obtained with the napB  flanking
primers were sequenced. The napB  loci of Cjd2  strains
RM2095, RM3782 and SSI 5384 contained an approx.
520 bp deletion extending from nt -23 to nt 495 (data not
shown). All three deletions had identical endpoints; how-
ever, single nucleotide polymorphisms present in the
napB amplicon sequences indicated that all three strains
were genetically distinct. Interestingly, three of the four
Cjd1 strains contained an extra G at napB nt 15, resulting
in a truncated NapB; thus, of the eight Cjd1 and Cjd2
strains, only RM2096 would be predicted to encode a full-
length, and presumably functional, NapB protein.
Similarly, the amplicons obtained with the napA flanking
primers were sequenced. As with napB, single nucleotide
polymorphisms are present also in the amplicon
Identification of C. jejuni subsp. doylei strains by multiplex PCR Figure 1
Identification of C. jejuni subsp. doylei strains by multiplex PCR. A. napAB multiplex PCR. C. jejuni genomic DNAs 
were amplified with either the nap mpx 1 ("1") or mpx 2 ("2") primer sets; the PCRs were run on a 1% agarose gel. D1: Cjd 
strain RM2095; D2: Cjd strain 269.97; D3: Cjd strain RM2096; D4: Cjd strain CCUG 18266; J1: Cjj strain NCTC 11168; J2: Cjj 
strain RM1221. Band sizes in bp are indicated on the left side of the gel. B. Combination speciation and subspeciation PCR. 
Campylobacter genomic DNAs were amplified with the combined nap mpx 2 and thermophilic lpxA Campylobacter speciation 
primer sets; PCRs were run on a 2% agarose gel. Cj: Cjj strain NCTC 11168; D1: Cjd strain CCUG 18266; D2: Cjd strain 
269.97; Cc: C. coli strain RM2228; Cl: C. lari strain RM2100; Cu: C. upsaliensis strain RM3195; Ch: C. helveticus strain ATCC 
51209. Band sizes in bp are indicated on the right side of the gel. Bands resulting from the speciation primer sets are indicated 
with an asterisk (*).BMC Microbiology 2007, 7:11 http://www.biomedcentral.com/1471-2180/7/11
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sequences of five of the eight strains, indicating that these
five strains are different. The remaining strains, ATCC
49350, ATCC 49351 and CCUG 18266, have identical
napA sequences. As predicted, all eight Cjd napA genes
contain 2761 bp deletions that extend from napA (nt 493)
into napG; unexpectedly, however, all eight deletions have
identical endpoints. Amplification and sequencing of the
napA loci from an additional 19 Cjd isolates also revealed
the presence of identical napA deletions.
Discussion
The apparent absence of the genes encoding nitrate
reductase (napA and napB) in Cjd strain RM2095 corre-
lated well with the nitrate reduction-negative phenotype
characteristic of this subspecies. Thus, we reasoned that a
potential subspeciation marker for C. jejuni would be the
nap locus, specifically napA and napB, and we developed
therefore a napA/B multiplex PCR method to subspeciate
C. jejuni. Amplification results indicate that this nap mul-
tiplex PCR method, using internal and flanking primer
sets for napA and napB, can be used to subspeciate unam-
biguously C. jejuni: Cjd strains (D1-4: Fig. 1A) can be dis-
tinguished readily from Cjj  strains (J1-2: Fig. 1A).
Moreover, different banding patterns were observed with
Cjj and Cjd using nap mpx1 or nap mpx2, suggesting that
either multiplex primer set is sufficient to subspeciate C.
jejuni. The almost total concordance between the subspe-
cies identification of 188 C. jejuni strains and the multi-
plex PCR results indicates that the new multiplex PCR is
robust and can be used successfully to subspeciate C.
jejuni. One strain, the Penner HS:63 reference strain, clas-
sified originally as Cjj, was identified as Cjd by our assay,
suggesting a potential flaw in the PCR method. However,
identification of a strain as Cjd by our method requires a
deletion in napA and/or napB. Since a deletion in either of
these two genes would lead necessarily to a loss of nitrate
reductase activity, C. jejuni strains containing such defects
would be, by definition Cjd, regardless of the original clas-
sification. Therefore, the Penner HS:63 reference strain
was either not subspeciated or was subspeciated incor-
rectly. Finally, combination of the napA/B  multiplex
method with an lpxA multiplex method designed to speci-
ate thermophilic Campylobacters permits the speciation
and subspeciation of thermophilic Campylobacters with a
single amplification reaction. Combination of the two
methods is especially important when the species identi-
fication of a Campylobacter strain is unknown, as C. coli
and C. upsaliensis strains may be confused potentially with
Cjj (although not Cjd) strains if the nap multiplex method
is used solely.
Currently, Cjd strains are subspeciated using the nitrate
reductase assay, an assay used initially also in this study to
identify Cjd strains. Although the nitrate reductase assay is
relatively easy to perform, the multiplex PCR methods
described here have several advantages over the nitrate
reductase assay. First, subspeciation of C. jejuni strains, as
well as the speciation/subspeciation of thermophilic
Campylobacters, can be accomplished with this assay in a
matter of hours, compared to the 2–3 days necessary for
the nitrate reductase assay, and in a single amplification
reaction. Second, the nitrate reductase assay requires a
pure culture. Mixtures of Campylobacter strains of the same
species or strains representing different species occur often
during isolation [3,18,19] and would be problematic with
regards to phenotypic assays; mixtures of Cjj and Cjd cells
would type as Cjj. In contrast, the multiplex PCR method
does not require a pure culture and would identify the
species/subspecies comprising such a mixture. In fact, the
multiplex speciation method identified successfully each
species in a mixture of four thermophilic Campylobacter
genomic DNAs (data not shown). Third, the nitrate
reductase assay requires often more than a single colony
for accurate identification. However, the multiplex PCR
method requires at most only a single colony. Indeed, 19
of the Cjd genomic DNAs used in this study were obtained
by boiling a single storage bead in 10 mM Tris pH 8.0,
indicating that strains in storage at -80°C do not even
have to be grown out to be characterized. Finally, the
nitrate reductase assay does lead occasionally to false
identification. One of the strains in this study, identified
initially as Cjd, was determined by the multiplex PCR
method to be Cjj. A repeat of the nitrate reductase assay on
this strain indicated that it was, in fact, Cjj and that the
original nitrate reductase identification was in error.
Taken together, these results indicate that the napA/B mul-
tiplex PCR method described here is a valuable tool for
clinical and research laboratories and can be used success-
fully to subspeciate rapidly C. jejuni strains and speciate
thermophilic Campylobacters when combined with the
lpxA multiplex PCR method.
An unexpected outcome of this study arose from the
sequencing of the Cjd napA and napB amplicons. Some
Cjd strains contained deletions in napB (Cjd2) and some
contained apparently full-length napB  genes (Cjd1),
although point mutations in many of the Cjd1 napB genes
would result in non-functional proteins; however, all 27
characterized Cjd strains contained identical napA dele-
tions of 2761 bp. Based on the presence of these identical
napA deletions, it appears that the Cjd strains, isolated on
four continents over at least two decades, share a common
ancestor. Furthermore, as the defining phenotype of Cjd is
the absence of nitrate reduction, the evidence suggests
strongly that Cjd arose from a single evolutionary event,
i.e. the napA deletion, with the divergence at napB occur-
ring somewhat later; deletion of the gene encoding the
large subunit of nitrate reductase would remove the con-
straint maintaining a functional small subunit-encoding
gene. Obviously, further experiments will be necessary toBMC Microbiology 2007, 7:11 http://www.biomedcentral.com/1471-2180/7/11
Page 6 of 8
(page number not for citation purposes)
validate this hypothesis. Such experiments would entail
the isolation and characterization of additional Cjd iso-
lates, facilitated by the multiplex PCRs described above.
Although the results presented here will need to be inves-
tigated further, they nevertheless provide intriguing
insights into the origin of this subspecies.
Conclusion
Campylobacter jejuni subsp. doylei strains are isolated infre-
quently. They are isolated primarily from human clinical
patients and often from blood cultures, suggesting that
they may be more pathogenic than Cjj strains. However,
little is known about the doylei subspecies, especially with
regards to the environmental reservoirs for this organism;
no animal host has been yet identified for Cjd [20]. Cjj
strains are isolated often from avian hosts. The absence of
Cjd from avian sources, such as poultry, may be due to the
lower maximum growth temperature (37°C) for this sub-
species. This lower growth temperature may restrict Cjd
strains to other hosts with lower normal body tempera-
tures, such as swine and domestic pets. It may influence
also the isolation of Cjd at the clinical level since enrich-
ment and selection of C. jejuni as a whole is normally per-
formed at 42°C, precluding the isolation of most Cjd
strains. Also, antibiotics used in typical C. jejuni isolation
media may restrict the growth of some Cjd strains.
The multiplex PCR method presented in this study will
enhance greatly the identification of Cjd  strains from
human clinical, veterinary and environmental samples.
Since this PCR does not require large numbers of cells or
pure cultures, Cjd strains can be identified even when they
comprise only a small subset of the overall population.
Removing the need for enrichment or selection would
reduce the isolation bias that might minimize or elimi-
nate detection of Cjd  strains. Finally, we have demon-
strated here that PCR identification of Cjd strains can be
performed using only the cells coating bacterial storage
beads from -80°C freezer stocks. Thus, strains identified
only as C. jejuni can be re-assessed rapidly without the
necessity of growing the strains out to purity. This was
instrumental in identifying, for example, an HS:63 Penner
serotype reference strain, identified initially as Cjj, as a Cjd
strain; several other strains identified only as C. jejuni may
be, in fact, C. jejuni subsp. doylei.
Methods
Bacterial strains, growth conditions and chemicals
Campylobacter strains used in this study are listed in Table
2. All Cjd strains were cultured routinely at 37°C under
microaerophilic conditions (5% O2, 10% CO, and 85%
N2) on Anaerobe basal agar (ABA; Oxoid, Basingstoke,
UK) amended with 5% (v/v) laked horse blood (Hema
Resource & Supply, Aurora, OR). All chemicals were pur-
chased from Sigma-Aldrich (St. Louis, MO) or Fisher Sci-
entific (Houston, TX). PCR enzymes and reagents were
purchased from New England Biolabs (Beverly, MA) or
Epicentre (Madison, WI). DNA sequencing chemicals and
capillaries were purchased from Applied Biosystems (Fos-
ter City, CA). Sequencing and PCR oligonucleotides were
purchased from MWG-Biotech (High Point, NC).
Phenotypic characterization of C. jejuni subsp. doylei 
strains
To determine nitrate reduction in C. jejuni, nitrate disks
and anaerobic nitrate reagents A and B (Remel, Lenexa,
KS) were used. Zinc dust was obtained from BioMérieux.
Cjj strain NCTC 11168 and Cjd strain ATCC 49350 were
used as controls for the procedure. Each Cjd strain was
streaked onto ABA agar supplemented with 5% horse
blood and grown for 48 h as described above. A nitrate
disk was then placed on a thick zone of growth on the
Table 2: Campylobacter strains used in this study
Straina Description Location Reference or source
NCTC 11168 Campylobacter jejuni subsp. jejuni; Lior 4, Penner HS:2 UK Human clinical isolate; [22].
RM1221 Campylobacter jejuni subsp. jejuni; Penner HS:53 USA Chicken carcass; [19].
81–176 Campylobacter jejuni subsp. jejuni; Penner HS:23,36 USA Human clinical isolate; [23, 24].
ATCC 49350 Campylobacter jejuni subsp. doylei Germany Human clinical isolate; [4].
ATCC 49351 Campylobacter jejuni subsp. doylei Australia Human clinical isolate; [25].
CCUG 18266 Campylobacter jejuni subsp. doylei Germany Human clinical isolate; [4].
RM2095 Campylobacter jejuni subsp. doylei USA Mabel Nicholson; human blood.
RM2096 Campylobacter jejuni subsp. doylei USA Mabel Nicholson; human clinical isolate.
RM3782 Campylobacter jejuni subsp. doylei South Africa Human clinical isolate.
SSI 5384 Campylobacter jejuni subsp. doylei Denmark Stephen On; human clinical isolate.
269.97 Campylobacter jejuni subsp. doylei South Africa Human blood.
RM2228 Campylobacter coli USA Chicken carcass; [26].
RM2100 Campylobacter lari USA Human clinical isolate; [26].
RM3195 Campylobacter upsaliensis South Africa Human clinical isolate; [26].
ATCC 51209T Campylobacter helveticus Switzerland Feline isolate.
a. T: type strain.BMC Microbiology 2007, 7:11 http://www.biomedcentral.com/1471-2180/7/11
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plate and incubated for an additional 24 h under the same
conditions. The nitrate disk was removed subsequently
and placed in a sterile tube. One drop of both reagents A
and B were added to the disk. Reduction of nitrate is indi-
cated by a color change (clear to red); if no color change
was observed after 3 min, zinc dust was added. A color
change prior to the addition of zinc is indicative of Cjj and
a color change only after addition of zinc is indicative of
Cjd.
Multiplex PCR
Genomic DNA from the Cjd strains in Table 2 was pre-
pared using the Wizard Genomic DNA kit (Promega,
Madison, WI) according to the manufacturer's protocols.
Additional Cjd genomic DNAs were prepared by boiling
single Microbank bacterial storage beads (Pro-Lab, Austin,
TX) from freezer stocks for 5 min in 100 μl of 10 mM Tris
pH 8.0. Genomic DNA from other Campylobacter strains
was prepared as described [21]. nap multiplex PCRs were
performed on a Tetrad thermocycler (Bio-Rad, Hercules,
CA) with the following settings: 30 s at 94°C; 30 s at
53°C; 2 min at 72°C (30 cycles). Each amplification mix-
ture contained 50 ng genomic DNA, 1× PCR buffer (Epi-
centre), 1× MasterAmp enhancer (Epicentre), 2.5 mM
MgCl2, 250 μM each dNTP, 50 pmol each primer (Table
1), and 1 U Taq polymerase (New England Biolabs). nap/
lpxA  multiplex PCRs were performed under similar
parameters, with a final MgCl2 concentration of 2.0 mM;
additionally, 30 pmol of the KK2 primer (Table 1) and 10
pmol of the lpxAC. coli, lpxAC. jejuni, Cl0122 and lpxAC.
upsaliensis primers (Table 1) were added to each reaction.
DNA sequencing
Cycle sequencing reactions were performed on a Tetrad
thermocycler using the ABI PRISM BigDye terminator
cycle sequencing kit (version 3.1) and standard protocols.
All extension products were purified on DyeEx 96 well
plates (Qiagen). DNA sequencing was performed on an
ABI PRISM 3130XL Genetic Analyzer (Applied Biosys-
tems) using the POP-7 polymer and ABI PRISM Genetic
Analyzer Data Collection and ABI PRISM Genetic Ana-
lyzer Sequencing Analysis software.
GenBank accession numbers
The partial Cjd napA and napB sequences were submitted
to GenBank and have the following accession numbers:
ATCC 49350 napA: [GenBank:EF218724 ]; ATCC 49350
napB: [GenBank: EF218725]; ATCC 49351 napA: [Gen-
Bank: EF218726]; ATCC 49351 napB: [GenBank:
EF218727]; RM2095 napA: [GenBank: EF218728];
RM2095  napB: [GenBank: EF218729]; RM2096 napA:
[GenBank: EF218730]; RM2096 napB: [GenBank:
EF218731]; RM3782 napA: [GenBank: EF218732]:
RM3782  napB: [GenBank: EF218733]; SSI 5384 napA:
[GenBank: EF218734]; SSI 5384 napB: [GenBank:
EF218735]; CCUG 18266 napA: [GenBank: EF218736];
CCUG 18266 napB: [GenBank: EF218737]; 269.97 napA:
[GenBank: EF218738]; 269.97 napB: [GenBank:
EF218739].
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